N61.23
Granulomatous mastitis, bilateral breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Granulomatous mastitis, bilateral breast (ICD-10 Code N61.23), is a rare inflammatory condition affecting both breasts. It is characterized by the formation of granulomas, which are clusters of immune cells that develop in response to inflammation. This condition can cause swelling, pain, and other changes in breast tissue, mimicking infections or even cancer. Understanding its causes, symptoms, and treatment options can help in managing this complex condition effectively.
Causes & Symptoms
Clinical Causes: Unknown, but possible autoimmune reactions where the body's immune system mistakenly attacks breast tissue. Infections, such as certain bacterial, fungal, or tuberculosis infections, which may lead to granuloma formation. Hormonal influences, with some studies suggesting associations with pregnancy or breastfeeding, though these are not definitive causes. Previous breast procedures or trauma that might trigger inflammatory responses. Chronic inflammatory conditions that extend to breast tissue, leading to granulomatous responses.
Key Symptoms: Swelling and firmness in both breasts. Pain or tenderness, often persistent or worsening over time. Redness or warmth of the breast skin. Presence of lump-like areas within breast tissue. Nipple changes, including retraction or discharge. Skin lesions or ulcerations in some cases. General discomfort, which may affect daily activities.
Diagnostic & Treatment
Diagnosis Path: Breast examination to assess swelling, masses, or skin changes. Imaging tests such as ultrasound or MRI to visualize tissue abnormalities. Fine-needle aspiration or biopsy to obtain tissue samples for microscopic examination. Histopathological analysis revealing granulomas composed of immune cells. Laboratory tests to rule out infectious causes or other inflammatory diseases. Cultures or special stains if an infectious etiology is suspected.
Treatment Protocols: Anti-inflammatory medications, such as corticosteroids, to reduce immune-mediated inflammation. Antibiotics or antifungal agents if an infectious cause is identified. Surgical intervention might be necessary to remove granulomatous tissue or abscesses, especially if symptoms persist or complications arise. Immunosuppressive therapy in cases with suspected autoimmune etiology. Supportive care, including pain management and breast support measures. Close monitoring to track response and detect any recurrence or complications.
Clinical Advice & FAQs
Billing Guidance
Is N61.23 a billable ICD-10 code?
Yes, N61.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N61.23?
Clinical documentation must specify the nature of Granulomatous mastitis, bilateral breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
